Category Archives: Gsk

FDA Panelists Vote to Ease Up on Avandia

A significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the current restrictive label and distribution regulations affecting the type 2 drug Avandia.

Avandia (rosiglitazone), manufactured by GlaxoSmithKline, was introduced in